STRATAFIX sutures for closing cranial and spine surgical wounds
Official title: Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
Run by University of Michigan · NCT07225101 · Data updated 2026-11-12
This project will test STRATAFIX sutures for closing cranial and spine surgical wounds in adults to learn about long-term safety and healing.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | University of Michigan Academic / other |
| Locations | 1 site (Lansing, Michigan) |
| Status | Recruiting |
| Started | November 1, 2025 |
| Main results expected | June 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | November 5, 2025 |
| Trial ID | NCT07225101 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults having cranial or spine neurosurgical procedures (elective or emergency) that require multilayer suture closure and who do not have allergy to suture materials are appropriate candidates.
✕Probably not a fit
Patients with prior surgical wound dehiscence, active wound infection, or known allergy to the suture materials are excluded and unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase 4 study enrolls adults undergoing elective or emergent cranial or spinal neurosurgery that requires multilayer wound closure and uses STRATAFIX PDS sutures, with Monocryl listed as a comparator. Participants will have their wound outcomes, surgical site infections, dehiscence, and tissue reactions tracked over time to gather long-term safety data. Because STRATAFIX is already FDA-approved, the focus is on real-world performance in neurosurgical applications rather than initial efficacy. Collected information will inform best practices for wound closure in brain and spine procedures.
Why it matters
Potential benefit: If successful, the study could show STRATAFIX provides reliable long-term wound closure with low rates of infection and dehiscence for neurosurgical patients.
How similar studies have gone: STRATAFIX is FDA-approved and has shown good performance for soft-tissue closure in other surgical specialties, but neurosurgery-specific long-term comparative data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Elective or emergent surgical approaches for cranial or spine neurosurgical approaches, requiring sutures for wound closure, requiring multilayer wound closure Exclusion Criteria: * Patients with prior surgical wound dehiscence or infection * Patients with allergy to suture material
Where it's running
-
University of Michigan Health Sparrow
Lansing, Michigan, United States Recruiting
Study contacts
- Principal investigator: Michael Karsy, MD, PhD, MSc — University of Michigan
- Study coordinator: Karen Sagher
- Email: kfrisch@med.umich.edu
- Phone: 734-232-4843
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-based EEG for better stroke and post-cardiac arrest outcomes
Researchers are testing whether a simple subhairline EEG patch plus AI can help predict outcomes after cardiac arrest and detect brain bleeds in stroke patients.
-
PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury
This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Depth Electrode Monitoring after Traumatic Brain Injury
This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.
-
Understanding growth hormone deficiency after a brain injury in adults
This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.
-
Electrical stimulation-assisted exercise for people with lower limb paralysis
This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.